【Moderna疫苗完成一期人體試驗：受試者產生100%免疫反應】Mordena公司14日聲明，在早期人體試驗中，其疫苗在所有45名受試者身上都產生了免疫反應。雖這不意味着疫苗成功，但是是疫苗早期開發重要的一步。不過超過一半的受試者都報告了副作用。近期該公司將開展下一期試驗[强] $Moderna, Inc.(MRNA)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Congratulations to Moderna!